# A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.

> **NCT00198055** · PHASE2 · COMPLETED · sponsor: **Indiana University** · enrollment: 25 (actual)

## Conditions studied

- Asperger's Disorder
- Pervasive Developmental Disorder

## Interventions

- **DRUG:** aripiprazole

## Key facts

- **NCT ID:** NCT00198055
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198055, "A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00198055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*